var data={"title":"Acyclovir (topical): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Acyclovir (topical): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/387510?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=acyclovir-topical-drug-information\" class=\"drug drug_general\">see &quot;Acyclovir (topical): Drug information&quot;</a> and <a href=\"topic.htm?path=acyclovir-topical-patient-drug-information\" class=\"drug drug_patient\">see &quot;Acyclovir (topical): Patient drug information \t&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908397\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Sitavig;</li>\n      <li>Zovirax</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908398\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Zovirax</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10456705\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Antiviral Agent, Topical</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10456711\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=acyclovir-topical-drug-information\" class=\"drug drug_general\">see &quot;Acyclovir (topical): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric: <b>Herpes labialis (cold sores):</b> Topical cream: Children &ge;12 years and Adolescents: Apply 5 times/day for 4 days</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Herpes labialis (cold sores):</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Buccal tablet: Apply one 50 mg tablet as a single dose to the upper gum region (canine fossa)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Topical cream: Apply 5 times/day for 4 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Mucocutaneous HSV, nonlife-threatening, immunocompromised: </b> Ointment: <sup>1</sup>/<sub>2</sub>&quot; ribbon of ointment for a 4&quot; square surface area every 3 hours (6 times/day) for 7 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Genital HSV:</b> Topical ointment: Initial episode: 1/2&rdquo; ribbon of ointment for a 4&rdquo; square surface area every 3 hours (6 times daily) for 7 days</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment:</b> There are no dosage adjustments provided in the manufacturer&rsquo;s labeling; however, dosage adjustment is unlikely due to low systemic absorption.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment:</b> There are no dosage adjustments provided in the manufacturer&rsquo;s labeling; however, dosage adjustment is unlikely due to low systemic absorption.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908562\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Zovirax: 5% (5 g) [contains cetostearyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ointment, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Zovirax: 5% (30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 5% (5 g, 15 g, 30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Buccal: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Sitavig: 50 mg [contains milk protein concentrate]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7912809\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F11277504\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Buccal tablet:</b> Apply within 1 hour after onset of prodromal symptoms and before appearance of any signs of lesions. Apply tablet with a dry finger immediately after removing it from packaging. Place tablets to the upper gum just above the incisor tooth (canine fossa) on the same side of the mouth as the prodromal symptoms and hold in place with slight pressure over the upper lip for 30 seconds to ensure adhesion. The rounded side of the tablet should be placed on the upper gum (for comfort purposes, does not affect efficacy). Do not crush, chew, suck, or swallow. If tablet falls off within the first 6 hours, reposition the same tablet immediately or apply a new tablet. If tablet is swallowed within the first 6 hours, drink a glass of water and apply a new tablet. If tablet falls out or is swallowed after the first 6 hours, do not reapply. Patients may eat and drink normally while tablet is in place. Avoid gum chewing, brushing teeth, wearing an upper denture or touching/pressing the tablet after placement. Rinse mouth gently if teeth need to be cleaned while the tablet is in place. Drink plenty of liquids in case of dry mouth.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Topical: </b>Cream or ointment: Apply as early as possible following the onset of prodromal symptoms or when lesions appear.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cream: Not for use on the genitals. Ensure the face and/or lips are clean and dry. Not for use in the eye, mouth, or mucous membranes. Wash hands with soap and water prior to application and after application. Apply an amount to sufficiently cover the affected area, including the outer margin. Avoid unnecessary rubbing of the affected area. Do not apply other topical products to the affected area during therapy.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ointment: Use a fingercot or rubber glove when applying ointment to prevent autoinoculation of other body sites or transmission of infection to other persons. Not for use in the eye.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908490\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Buccal tablet: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); excursions permitted between 15&deg;C and 30&deg;C (59&deg;F and 86&deg;F). Protect from moisture.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream: Store at or below 25&deg;C (77&deg;F); excursions permitted between 15&deg;C and 30&deg;C (59&deg;F and 86&deg;F).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ointment: Store at controlled room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F) in a dry place.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10456706\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Buccal tablet: Treatment of recurrent herpes labialis (cold sores) in immunocompetent patients (FDA approved in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical (cream): Treatment of recurrent herpes labialis (cold sores) in immunocompetent patients (FDA approved in ages &ge;12 years and adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical (ointment): Management of initial genital herpes and in limited, nonlife-threatening mucocutaneous HSV infections in immunocompromised patients (FDA approved in adults)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908396\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Acyclovir may be confused with ganciclovir, Retrovir, valacyclovir</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Zovirax may be confused with Doribax, Valtrex Zithromax, Zostrix, Zyloprim, Zyvox</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Opthavir [Mexico] may be confused with Optivar brand name for azelastine [U.S.]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908486\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Central nervous system: Lethargy (buccal tablet)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Dermatologic: Erythema (buccal tablet), local pain (ointment; mild; includes transient burning and stinging), skin rash (buccal tablet)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gastrointestinal: Aphthous stomatitis (buccal tablet), gingival pain (buccal tablet)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Local: Application site irritation (buccal tablet), application site reaction (cream; including dry lips, desquamation, dryness of skin, cracked lips, burning skin, pruritus, flakiness of skin, and stinging on skin)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Rare but important or life-threatening: Anaphylaxis, eczema</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908472\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Buccal tablet:</i> Hypersensitivity to acyclovir, valacyclovir, milk protein concentrate or any component of the formulation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Cream, ointment:</i> Hypersensitivity to acyclovir, valacyclovir, or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908473\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Dermatologic toxicity:  Cream may be irritating and cause contact sensitization. The sensitizing ingredient has not been identified.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Appropriate use: Genital herpes: Physical contact should be avoided when lesions are present; transmission may also occur in the absence of symptoms. Treatment should begin with the first signs or symptoms. There are no data to support the use of acyclovir ointment to prevent transmission of infection to other persons or prevent recurrent infections if no signs or symptoms are present.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Appropriate use: Herpes labialis: Treatment should begin with the first signs or symptoms.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Immunocompromised patients: Buccal tablet, cream: Use and safety has not been studied; use with caution.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Buccal tablet: Apply to the area of the upper gum above the incisor tooth on the same side as the symptoms; do not apply to the inside of the lip or cheek.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Cream: For external use only to the lips and face; do not apply to eye or inside the mouth or nose, or to any mucous membranes.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Ingredient precaution: Some products may contain milk protein concentrate.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Ointment: For cutaneous use only; do not use in the eye.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26522737\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13298683\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7912821\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=15937&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Talimogene Laherparepvec: Antiherpetic Antivirals may diminish the therapeutic effect of Talimogene Laherparepvec. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7912816\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">B (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7912817\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Teratogenic effects were not observed in animal studies. When administered orally, acyclovir crosses the placenta. Refer to the Acyclovir (Systemic) monograph for details. The amount of acyclovir available systemically following topical application of the cream or ointment is significantly less in comparison to oral doses.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7908491\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Acyclovir is converted to acyclovir monophosphate by virus-specific thymidine kinase then further converted to acyclovir triphosphate by other cellular enzymes. Acyclovir triphosphate inhibits DNA synthesis and viral replication by competing with deoxyguanosine triphosphate for viral DNA polymerase and being incorporated into viral DNA.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9770059\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Minimal</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Buccal tablet: Single dose application of buccal tablets containing 50 mg to the buccal mucosa provided mean maximum salivary concentrations 8 hours after tablet application. Plasma concentrations were delayed (undetectable at 5 hours) and subsequently below antiviral activity concentration (0.018 to 0.055 mcg/mL). </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cream: Plasma concentrations following topical application of the cream were below the limit of detection in 5/6 male volunteers (&lt;0.01 &mu;M) and 0.014 &mu;M in one subject. </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ointment: Following application of the ointment to patients with varicella-zoster infection, acyclovir plasma concentrations were &lt;0.01 to 0.28 mcg/mL in patients with normal renal function and &lt;0.01 to 0.78 mcg/mL in a patient with renal impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Urine (Buccal tablet: Primarily renally excreted unchanged; Cream: 0.04% of the daily dose; Ointment: &lt;0.02% to 9.4% of the daily dose)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7913156\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Zovirax External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (5 g): $955.80</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Acyclovir External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (30 g): $797.59</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Zovirax External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (30 g): $1,656.23</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Sitavig Buccal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">50 mg (2): $1,144.90</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10961952\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>A.C.V. (TH);</li>\n      <li>Acic (AE, CY, EE, IE, KW, LV, QA);</li>\n      <li>Acic Creme (DE);</li>\n      <li>Aciclidan (DK);</li>\n      <li>Aciclomed (BE);</li>\n      <li>Aciclor (VE);</li>\n      <li>Aciclosina (PT);</li>\n      <li>Acifar (ID);</li>\n      <li>Aciherpin (PH);</li>\n      <li>Acirax (LK, VN);</li>\n      <li>Acivir (CH, ET, IL, IN, LV, QA);</li>\n      <li>Acivir Cold Sore Cream (AU);</li>\n      <li>Acivirex (GT, HN, NI, SV);</li>\n      <li>Activir (FR);</li>\n      <li>Acyvir (EC);</li>\n      <li>Aherp (UA);</li>\n      <li>Anti (SE);</li>\n      <li>Antix (NO);</li>\n      <li>Astad (HK);</li>\n      <li>Atsyvir (UA);</li>\n      <li>Avir (VE);</li>\n      <li>Avorax (SG);</li>\n      <li>Chemists' Own Cold Sore Cream (AU);</li>\n      <li>Cicloferon (CR, DO, GT, PA, SV);</li>\n      <li>Cicloviral (CO);</li>\n      <li>Civar (ET, LB, QA);</li>\n      <li>Clinovir (ID, TH);</li>\n      <li>Clovir (KW, SA, TW);</li>\n      <li>Covelay (PH);</li>\n      <li>Covir Cream (TH);</li>\n      <li>Cycloherp (HK, JO);</li>\n      <li>Cyclomed (IL);</li>\n      <li>Cyclostad (PH);</li>\n      <li>Cyclovax (HK, TR);</li>\n      <li>Cyclovir (IN);</li>\n      <li>Danovir (ID);</li>\n      <li>Declovir (ET, HK);</li>\n      <li>Deherp (TW);</li>\n      <li>Dravyr (SG);</li>\n      <li>Ecuvir (EC);</li>\n      <li>Entir (TH);</li>\n      <li>Entir Cream (HK);</li>\n      <li>Eurovir (PY);</li>\n      <li>Expit (UY);</li>\n      <li>Ezopen Creme (BR);</li>\n      <li>Herpavir (JO);</li>\n      <li>Herpecid (KR);</li>\n      <li>Herpesin (CZ);</li>\n      <li>Herpevir (FR);</li>\n      <li>Herpex (IN);</li>\n      <li>Herpizing (ET);</li>\n      <li>Imavir (AE);</li>\n      <li>Immunovir (MT);</li>\n      <li>Lisovyr Cream (AR);</li>\n      <li>Lisovyr Crema (CL);</li>\n      <li>Lovire (ZA);</li>\n      <li>Lovrak (JO, KW, QA);</li>\n      <li>Marvir (TH);</li>\n      <li>Matrovir (ID);</li>\n      <li>Medovir (MY);</li>\n      <li>Novirax (QA);</li>\n      <li>Oppvir (TW);</li>\n      <li>Poviral (AR);</li>\n      <li>Qualiclovir (HK);</li>\n      <li>Remex (FR);</li>\n      <li>Soviclor (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Ultravir (BD);</li>\n      <li>Univir (ET);</li>\n      <li>Vicorax (TW);</li>\n      <li>Viramed (ZW);</li>\n      <li>Viratak (ZW);</li>\n      <li>Viratop (BE);</li>\n      <li>Virest (LK);</li>\n      <li>Virex (CO);</li>\n      <li>Virless (SG);</li>\n      <li>Virogon (TH);</li>\n      <li>Virolox (HR);</li>\n      <li>Virzin (DE);</li>\n      <li>Vivir (KR);</li>\n      <li>Zeven (MY);</li>\n      <li>Zevin (TH);</li>\n      <li>Zoral (HK, MY, SG);</li>\n      <li>Zorax (SG);</li>\n      <li>Zovir (DK, IS);</li>\n      <li>Zovirax (AE, AR, AU, BB, BE, BH, BM, BR, BS, CH, CL, CN, CY, CZ, EC, EE, EG, ES, FI, FR, GB, GY, HK, HR, ID, IE, IL, IS, JM, JO, KR, KW, LB, LK, LT, LU, LV, MT, MY, NL, NO, NZ, PE, PR, PT, PY, QA, RO, SA, SE, SK, TH, TR, TT, TW, UY, VN, ZA, ZW);</li>\n      <li>Zovirax Intensive (PL)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acyclovir-topical-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acyclovir-topical-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sitavig (acyclovir topical) [prescribing information]. Charleston, NC: Cipher Pharmaceuticals; October 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zovirax cream (acyclovir topical) [prescribing information]. Irvine, CA: Valeant Pharmaceuticals; April 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zovirax ointment (acyclovir topical) [prescribing information]. Irvine, CA: Valeant Pharmaceuticals; August 2011.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 15937 Version 122.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F7908397\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F7908398\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F10456705\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F10456711\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F7908562\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F7912809\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F11277504\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F7908490\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F10456706\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F7908396\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F7908486\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F7908472\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F7908473\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26522737\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13298683\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F7912821\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F7912816\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F7912817\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F7908491\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F9770059\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F7913156\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F10961952\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/15937|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=acyclovir-topical-drug-information\" class=\"drug drug_general\">Acyclovir (topical): Drug information</a></li><li><a href=\"topic.htm?path=acyclovir-topical-patient-drug-information\" class=\"drug drug_patient\">Acyclovir (topical): Patient drug information \t</a></li></ul></div></div>","javascript":null}